Zimmer Biomet Announces Departure of Group President Kevin Thornal

What Happened

• Zimmer Biomet Holdings, Inc. (ZBH) notified Kevin Thornal, Group President, Global Businesses and the Americas, on September 8, 2026 that his role is being restructured and he will depart the company effective September 30, 2026. The company filed an 8-K (Item 5.02) and issued a related press release on September 8, 2026 (Item 7.01).

Key Details

• Departure effective date: September 30, 2026.
• Severance: Mr. Thornal is eligible under the company’s Restated Executive Severance Plan to receive a lump-sum equal to 12 months of his annual base salary plus his target annual bonus, plus 12 months of COBRA premiums.
• Condition: Severance payments are conditioned on Mr. Thornal executing and not revoking a general release in favor of the company.
• Documents: The Severance Plan summary appears in the company’s April 1, 2026 proxy statement; the plan and its amendment were previously filed as exhibits to the company’s 10-Qs (Aug 6, 2018 and May 5, 2022). A press release was filed as Exhibit 99.1 to the 8-K.

Why It Matters

• This is a material executive change (Item 5.02) for the leadership of Zimmer Biomet’s Global Businesses and Americas. Investors should note the potential one-time cash cost tied to the severance arrangement and that the severance is contingent on a release. The filing does not disclose a successor, any change to financial guidance, or other operational impacts.